salmeterol xinafoate has been researched along with Preterm Birth in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beauchesne, MF; Blais, L; Cossette, B; Forget, A; Larivée, P; Lemière, C; Rey, E | 1 |
Falkay, G; Gáspár, R; Hajagos-Tóth, J; Kormányos, Z; Pál, A | 1 |
2 other study(ies) available for salmeterol xinafoate and Preterm Birth
Article | Year |
---|---|
Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Budesonide; Canada; Ethanolamines; Female; Fluticasone; Formoterol Fumarate; Humans; Infant, Low Birth Weight; Pregnancy; Pregnancy Complications; Premature Birth; Salmeterol Xinafoate; Treatment Outcome; Young Adult | 2014 |
Potentiation of the uterus-relaxing effects of β-adrenergic agonists with nifedipine: studies on rats and the human myometrium.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Drug Synergism; Drug Therapy, Combination; Female; Humans; Mifepristone; Models, Animal; Myometrium; Nifedipine; Oxytocics; Pregnancy; Premature Birth; Progesterone; Rats; Rats, Sprague-Dawley; Salmeterol Xinafoate; Tocolysis; Tocolytic Agents; Uterine Contraction | 2010 |